Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus

Patent No. EP2886108 (titled "Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus") was filed by DR Falk Pharma on Dec 23, 2013. The application was issued on Nov 2, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELLODI PHARMACEUTICALSNov 6, 2019COOLEY UK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2886108

DR FALK PHARMA
Application Number
EP13199278A
Filing Date
Dec 23, 2013
Status
Patent Maintained As Amended
Sep 30, 2022
Publication Date
Nov 2, 2022